A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page

Trilogy

The Next Generation Radiation Therapy for Cancer

 

Ask the Expert

Dr. Regine’s Bio Image

Get answers to your Trilogy questions.

Dr. Regine’s Bio | Q&A Archive

Note: This is for informational purposes only. Doctors cannot provide a diagnosis or individual treatment advice via e-mail. Please consult your physician about your specific health care concerns.

Related Content


 

The TrilogyTM System linear accelerator is the latest technology available in radiation treatment for cancer.

Trilogy combines the capabilities of other external beam radiation technologies -- including Cyberknife, Tomotherapy, and Novalis -- all in one state-of-the-art machine.

The University of Maryland Marlene and Stewart Greenebaum Cancer Center's (UMGCC) Department of Radiation Oncology was the first academic medical center in the region to introduce the fully-integrated TrilogyTM System.

RapidArc Enhances Already Powerful Trilogy Technology

Since the introduction of Trilogy in 2006, scientists at the University of Maryland have worked with Varian Medical Systems, makers of Trilogy, to develop a further refinement of the Trilogy System known as RapidArc. Trilogy with RapidArc technology now provides patients with the fastest, most precise targeted radiation therapy available.


For More Information

Read a Trilogy Patient Success Story.

WBAL-TV Health Alert: New Technology Treating Cancer

Interview with Dr. Mohan Suntha: New Approaches in Cancer Care Using Radiation Therapy


This page was last updated on: October 19, 2009.